BIOS — BioPlus Acquisition Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsAdventurousSmall Cap
- $271.14m
- $276.39m
Annual cashflow statement for BioPlus Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -0.14 | 2 |
| Non-Cash Items | -0.009 | -3.17 |
| Other Non-Cash Items | ||
| Changes in Working Capital | -0.625 | 0.48 |
| Change in Prepaid Expenses | ||
| Change in Accrued Expenses | ||
| Cash from Operating Activities | -0.774 | -0.691 |
| Other Investing Cash Flow Items | -235 | 0 |
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -235 | 0 |
| Financing Cash Flow Items | 225 | -0.068 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 236 | 0.196 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0.636 | -0.495 |